Eisai, Inc. | Eisai | North Carolina | state | 2014 | $117,680 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2014 | $57,885 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2014 | $13,840 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2014 | $11,365 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2014 | $8,340 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2014 | $5,969 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2014 | $5,583 | | tax credit/rebate |
Pozen, Inc. | Miravo Healthcare | North Carolina | state | 2014 | $5,426 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2014 | $1,644 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2014 | $6,118,950 | | tax credit/rebate |
GlaxoSmithKline, LLC (f/k/a SmithKline Beecham Corporation) | GlaxoSmithKline | Pennsylvania | state | 2014 | $3,353,317 | | tax credit/rebate |
Janssen Research & Development, LLC (f/k/a J&J Pharmaceutical Research & Development LLC) | Johnson & Johnson | Pennsylvania | state | 2014 | $2,207,905 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2014 | $1,144,884 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2014 | $957,730 | | tax credit/rebate |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2014 | $914,646 | | tax credit/rebate |
Amgen, Inc. | Amgen | Pennsylvania | state | 2014 | $608,537 | | tax credit/rebate |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2014 | $574,748 | | tax credit/rebate |
Auxilium Pharmacueticals, Inc. | Endo International | Pennsylvania | state | 2014 | $426,723 | | tax credit/rebate |
Sanofi US Services, Inc. | Sanofi | Pennsylvania | state | 2014 | $314,989 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2014 | $178,257 | | tax credit/rebate |
Callidus Biopharma, Inc. | Amicus Therapeutics | Pennsylvania | state | 2014 | $98,490 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2014 | $83,843 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2014 | $74,054 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2014 | $34,743 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2014 | $20,248 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2014 | $4,825 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | Pennsylvania | state | 2014 | $3,556 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2014 | $273,088 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2014 | $403,872 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2014 | $13,522 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2014 | $22,572 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2014 | $83,367 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2014 | $48,418 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2014 | $398,897 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2014 | $41,681 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2014 | $185,655 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2014 | $19,669 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2014 | $10,326 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2014 | $102,925 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2014 | $83,218 | | tax credit/rebate |
SANOFI AVENTIS US LLC | Sanofi | Washington | state | 2014 | $70,422 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2014 | $3,398,678 | | tax credit/rebate |
Moderna Therapeutics | Moderna Inc. | Massachusetts | state | 2014 | $450,000 | | tax credit/rebate |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2014 | $597,076 | | tax credit/rebate |
Synageva BioPharma | AstraZeneca | Massachusetts | state | 2014 | $1,021,550 | | tax credit/rebate |
PAREXEL International | Parexel International | Massachusetts | state | 2014 | $1,062,412 | | tax credit/rebate |
Foundation Medicine | Roche | Massachusetts | state | 2014 | $1,225,860 | | tax credit/rebate |
Biogen Idec | Biogen | Massachusetts | state | 2014 | $6,250,000 | | tax credit/rebate |
Moderna Therapeutics | Moderna Inc. | Massachusetts | state | 2014 | $300,000 | | tax credit/rebate |
Alnylam Pharmaceuticals | Alnylam Pharmaceuticals | Massachusetts | state | 2014 | $612,930 | | tax credit/rebate |
Merrimack Pharmaceuticals | Merrimack Pharmaceuticals | Massachusetts | state | 2014 | $633,361 | | tax credit/rebate |
Aegerion Pharmaceuticals | Amryt Pharma | Massachusetts | state | 2014 | $715,085 | | tax credit/rebate |
EMERGENT BIOSOLUTIONS INC | Emergent BioSolutions | Maryland | local | 2014 | $750,000 | | grant/loan hybrid program |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2014 | $100,000 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $2,578 | | property tax abatement |
PFIZER, INC | Pfizer | Tennessee | local | 2014 | $3,011 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $4,377 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $11,311 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $11,532 | | property tax abatement |
JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2014 | $12,315 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $37,127 | | property tax abatement |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2014 | $13,628,726 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2014 | $1,844,082 | | tax credit/rebate |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2014 | $1,508,236 | | tax credit/rebate |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2014 | $1,023,131 | | tax credit/rebate |
Doral/Pfizer | Pfizer | New York | local | 2014 | $607,052 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2014 | $452,064 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2014 | $432,501 | | tax credit/rebate |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2014 | $114,848 | | tax credit/rebate |
Albany Molecular | Curia Inc. | New York | local | 2014 | $98,411 | | tax credit/rebate |
Forest Laboratories, Inc. | AbbVie | New York | local | 2014 | $90,408 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2014 | $29,980 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2014 | $3,933 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | local | 2014 | $930,000 | | grant |
Hospira Inc. | Pfizer | Colorado | state | 2014 | $31,104 | | training reimbursement |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2014 | $63,126 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $207,247 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $5,509,471 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $5,509,471 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2014 | $764,142 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2014 | $1,028,677 | | enterprise zone |
C3i, Inc. | Merck | Pennsylvania | state | 2014 | $512,000 | | tax credit/rebate |
CSL Behring | CSL Limited | Pennsylvania | state | 2014 | $339,000 | | tax credit/rebate |
Spark Therapeutics Inc | Roche | Pennsylvania | state | 2014 | $201,000 | | tax credit/rebate |
Spark Therapeutics Inc | Roche | Pennsylvania | state | 2014 | $150,000 | | grant |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2014 | $740,512 | | training reimbursement |
Newlink Genetics Corporation | Lumos Pharma | Iowa | state | 2014 | $200,071 | | training reimbursement |
Emergent Biosolutions | Emergent BioSolutions | Maryland | local | 2014 | $250,000 | | infrastructure assistance |
Easel Biotechnologies, LLC | Bristol-Myers Squibb | United States | federal | 2014 | $1,201,621 | | federal grant |
Novartis Corporation | Novartis | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2013 | $150,000 | | grant |